Production (Stage)
GoodRx Holdings, Inc.
GDRX
$3.74
-$0.08-2.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.57% | 0.99% | 8.50% | 5.76% | 7.55% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.57% | 0.99% | 8.50% | 5.76% | 7.55% |
| Cost of Revenue | 7.19% | 14.27% | -37.59% | -27.35% | -25.32% |
| Gross Profit | 2.26% | 0.22% | 13.85% | 8.89% | 10.83% |
| SG&A Expenses | -7.04% | -9.91% | -9.02% | 12.44% | 9.18% |
| Depreciation & Amortization | 31.18% | 717.59% | -46.90% | 5.39% | 6.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -1.31% | 16.06% | -19.90% | 5.46% | 2.79% |
| Operating Income | 36.35% | -34.40% | 153.24% | 8.58% | 80.31% |
| Income Before Tax | 5,588.74% | 146.31% | 117.41% | -3.50% | -91.85% |
| Income Tax Expenses | 331.34% | 278.36% | 151.16% | 110.60% | -81.09% |
| Earnings from Continuing Operations | 1,195.34% | 126.05% | 110.30% | -88.61% | 69.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,195.34% | 126.05% | 110.30% | -88.61% | 69.33% |
| EBIT | 36.35% | -34.40% | 153.24% | 8.58% | 80.31% |
| EBITDA | 34.08% | -33.55% | 815.08% | 7.09% | 38.42% |
| EPS Basic | 1,219.23% | 127.57% | 111.17% | -87.52% | 67.50% |
| Normalized Basic EPS | 62.91% | -35.96% | 125.04% | 5.46% | 159.76% |
| EPS Diluted | 1,219.23% | 127.57% | 110.74% | -87.29% | 67.50% |
| Normalized Diluted EPS | 62.91% | -36.21% | 124.44% | 3.85% | 159.76% |
| Average Basic Shares Outstanding | -2.78% | -5.37% | -8.17% | -8.73% | -5.43% |
| Average Diluted Shares Outstanding | -2.66% | -4.88% | -6.03% | -7.14% | -5.43% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |